Clinical Outcomes for Postinfarct Ventricular Septal Defect Repair in a Large State-Wide Surgical Registry
Mohamad B Moumneh1, Mohammed A Quader2, Nicholas R Teman3
1Inova Center of Outcomes Research, Inova Heart and Vascular, Fairfax, Virginia.
The American Journal of Cardiology
|January 1, 2025
Summary
Surgical repair of post-myocardial infarction ventricular septal defects (VSD) has high mortality, especially with cardiogenic shock. Mechanical circulatory support and emergent surgery significantly increase mortality risk in these acute myocardial infarction patients.
Area of Science:
- Cardiology
- Cardiac Surgery
Background:
- Ventricular septal defect (VSD) is a severe complication of acute myocardial infarction (AMI).
- Delayed presentation of AMI increases VSD risk and mortality.
- Surgical repair outcomes for post-AMI VSD require further investigation.
Purpose of the Study:
- To assess clinical characteristics and mortality following surgical repair of post-AMI VSD.
- To evaluate trends in mortality, mechanical circulatory support (MCS) device use, and surgical approaches.
- To identify factors associated with in-hospital mortality after VSD repair.
Main Methods:
- Retrospective analysis of 79 patients undergoing surgical VSD repair post-AMI (May 2008-Jan 2020).
- Univariate and multivariable logistic regression models used to analyze in-hospital mortality.
- Key variables analyzed included age, ejection fraction, cardiogenic shock, MCS use, and surgical timing.
Main Results:
- In-hospital mortality was 35% (28/79 patients).
- Cardiogenic shock (79% vs 39%) and MCS device use (54% vs 4%) were significantly associated with mortality.
- Emergent surgery (71% vs 18%) and renal failure (48% vs 19%) also correlated with higher mortality.
Conclusions:
- Surgical repair of post-AMI VSD carries a high mortality rate, strongly linked to cardiogenic shock and MCS requirement.
- Emergent surgery and postoperative renal failure are critical indicators of poor outcomes.
- Improved patient selection via a Heart Team approach and novel therapies are essential for managing these complex cases.


